Evidence map›Paper›PMID 25347711›Full record

ArticleAmerican journal of respiratory cell and molecular biology2015

Isolation of epithelial, endothelial, and immune cells from lungs of transgenic mice with oncogene-induced lung adenocarcinomas.

Amlak Bantikassegn, Xiaoling Song, Katerina Politi

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. FPR1-dependent Pro-inflammatory Ccl4Respiratory research · 2025
    Article
  4. Systemic in utero gene editing as a treatment for cystic fibrosis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Locally organised and activated Fth1Nature communications · 2022
    Article
  11. Article
  12. Article
  13. Regenerative medicine technologies applied to transplant medicine. An update.Frontiers in bioengineering and biotechnology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Comprehensive phenotyping of endothelial cells using flow cytometry 1: Murine.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amlak Bantikassegn1 Yale Cancer Center.
Xiaoling Song
Katerina Politi
Yale Cancer Center · US

Funding

Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic MiceR01CA120247 · NCI · YALE UNIVERSITY · PI POLITI, KATERINA ABIGAIL · 2006 to 2014
$3.8M
NCI NIH HHS R01 CA120247
6 · The paper itself

Abstract

Genetically engineered mouse models of lung adenocarcinoma have proven invaluable for understanding mechanisms of tumorigenesis, therapy response, and drug resistance. However, mechanistic studies focused on studying these processes in tumor-bearing mouse lungs are confounded by the fact that, in most cases, relevant signaling pathways are analyzed in whole-lung preparations, which are composed of a heterogeneous mixture of cells. Given our increasing knowledge about the roles played by different subpopulations of cells in the development of lung adenocarcinoma, separating the major cellular compartments of the tumor microenvironment is recommended to allow for a precise analysis of relevant pathways in each isolated cell type. In this study, we optimized magnetic- and fluorescence-based isolation protocols to segregate lung epithelial (CD326/epithelial cell adhesion molecule-positive), endothelial (CD31-positive), and immune (CD45-positive) cells, with high purity, from the lungs of transgenic mice with mutant epidermal growth factor receptor-induced lung adenocarcinomas. This approach, which can potentially be extended to additional lung adenocarcinoma models, enables delineation of the molecular features of individual cell types that can be used to gain insight into their roles in lung adenocarcinoma initiation, progression, and response to therapy.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAnimalsCells, CulturedDisease Models, AnimalEndothelial CellsEpithelial CellsErbB ReceptorsFlow CytometryHumansImmunomagnetic SeparationLungLung NeoplasmsMacrophagesMice, TransgenicOncogenesEGFR protein, mouseErbB Receptorsepithelial cell adhesion moleculeepithelial cell isolationlung adenocarcinomatransgenic mouse models

Identifiers

PMID25347711
PMCPMC4491125
OpenAlexW2129437774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.